Alla studier
RekryteringNAINTERVENTIONELL

Stellate Ganglion Block for Long COVID Symptoms: A Randomized Controlled Trial

Researchers are investigating if a specific type of injection, known as a Stellate Ganglion Block (SGB), can help improve ongoing symptoms in adults who have long COVID. Long COVID can cause persistent problems such as extreme tiredness, memory issues, and difficulty breathing. In this study, participants will either receive the SGB injection, which contains a numbing medicine, or a dummy injection (placebo) of salt water. The injections are given in the neck. Over 26 weeks, the team will closely monitor how participants' symptoms change, looking at things like energy levels, thinking abilities, and overall well-being. The goal is to understand if this treatment offers real benefits compared to no active treatment, and to guide future care for long COVID.

Överblick

Status
Rekrytering
Fas
NA
Sponsor
Centre intégré universitaire de santé et de services sociaux de la Mauricie-et-du-Centre-du-Québec
Inskrivningsmål
40
Starta
05 feb 2026
Beräknad slutförande
01 feb 2027

Vad handlar denna studie om?

Many people who have had COVID-19 find that some symptoms, like extreme tiredness, breathlessness, and 'brain fog', can carry on for weeks or even months afterwards. This is often called long COVID. It can be really challenging and affect daily life.

Doctors are always looking for new ways to help people with long COVID. One treatment being explored is called a Stellate Ganglion Block (SGB). This is an injection given in the neck, near a cluster of nerves. The idea is that calming these nerves might help with some of the long COVID symptoms. This particular study is designed to see if the SGB, using a numbing medicine called bupivacaine, can make a difference.

To find out if the SGB truly works, this study uses a careful design. Some participants will receive the actual SGB injection, while others will get a 'dummy' injection (a placebo) of salty water. This helps researchers compare the effects accurately. Everyone will be monitored for about six months after the injection to see how their symptoms change and if their quality of life improves. The results will help doctors decide if SGB could be a useful treatment option for long COVID in the future.

Viktiga punkter

  • This study explores a new injection (Stellate Ganglion Block) for long COVID symptoms.
  • It aims to see if the injection helps with tiredness, 'brain fog', and breathing difficulties.
  • You might receive the active injection or a dummy (placebo) injection.
  • Participation involves an injection and follow-up for about 6 months.
  • Researchers will compare how symptoms change between the groups.
  • The results could help guide future treatments for long COVID.

Vem kan vara berättigad?

To join this study, you need to be an adult aged 18 or over. You must have had a confirmed COVID-19 infection (or a very likely case identified by a doctor) at least three months ago, and your long COVID symptoms must have been bothering you for at least 12 weeks and still be present. This includes feeling breathlessness and scoring at least 2 on a specific scale, and having a Post-COVID Functional Status Scale score of 2 or more, meaning your daily life is moderately affected.

There are also some important things that would prevent you from joining. For example, if you've already been diagnosed with ME (Myalgic Encephalomyelitis) or fibromyalgia, or if you're pregnant or breastfeeding, you wouldn't be able to take part. Also, if you've had a heart attack recently (in the last 12 weeks), are taking blood thinners, have glaucoma, or need oxygen for lung problems like emphysema, this study might not be safe for you. If you've had a Stellate Ganglion Block injection before, you also wouldn't be eligible. Importantly, you need to be able to read and understand French.

Kan denna studie passa dig?

Svara på dessa snabba frågor för att se om du kan vara berättigad. Detta är endast en vägledning — forskarteamet fattar det slutgiltiga beslutet.

  1. Är du 18 år eller äldre?
  2. Did you have COVID-19 at least 3 months ago with symptoms lasting at least 12 weeks?
  3. Do you have persistent breathing difficulties rated 2 or higher on the mMRC scale?
  4. Do your long COVID symptoms moderately affect your daily life (Post-COVID Functional Status Scale score 2 or more)?
  5. Are you able to read and understand French?
  6. Have you NOT had a heart attack in the last 12 weeks, nor do you take blood thinners, or have glaucoma, or need home oxygen?
Svara på varje fråga för att se ditt resultat.

Vad innebär deltagande?

If you decide to take part in this study, you will first go through checks to make sure you meet all the requirements. Once enrolled, you will be randomly assigned to one of two groups: either you'll receive the Stellate Ganglion Block (SGB) injection or a placebo (dummy) injection of salt water. Both injections are given in a similar way, using ultrasound guidance in your neck.

After the injection, you'll be followed closely for about 26 weeks (roughly 6 months). During this time, you'll have several scheduled appointments where you'll complete questionnaires about your symptoms, tiredness, memory, and how you feel overall. You'll also do some simple tests to check your physical abilities, like how far you can walk or how well you tolerate standing up. Your safety will be checked at each visit. If you're already taking medications for tiredness or memory issues, you should have been on a steady dose for at least 4 weeks before joining and should try not to change them during the study.

Potentiella risker och fördelar

Taking part in this study might offer some potential benefits, as the Stellate Ganglion Block could help improve your long COVID symptoms. However, it's also possible that you might receive the placebo injection and not experience any direct benefits from the treatment itself. As with any medical procedure, there are potential risks, such as discomfort or bruising at the injection site, or other rare side effects associated with injections in the neck. Your safety will be closely monitored throughout the study. It's important to remember that joining is completely voluntary, and you have the right to withdraw from the study at any time, for any reason, without it affecting your usual medical care.

Platser (1)

  • Centre hospitalier affilié universitaire régional
    Verifierat postnummer
    Trois-Rivières, Kanada· Rekrytering

Vanliga frågor

What is a Stellate Ganglion Block (SGB)?

It's an injection given in the neck near a group of nerves. Doctors are studying if it can help calm symptoms linked to long COVID.

Will I know if I get the real injection or the dummy one?

No, you won't know at the time. This is a common way to conduct studies to ensure results are fair and unbiased.

Hur länge kommer studien att pågå om jag deltar?

The active part of your participation will last for about 26 weeks, which is roughly six months, after your injection.

Do I have to stop my current medications?

No, if you're on stable medications for fatigue or memory for at least 4 weeks, you should continue them during the study.

Vad händer om jag ändrar mig efter att jag har gått med?

You are free to leave the study at any time, for any reason, and it won't affect your medical care.

Hur du får reda på mer

Marie-Claude Lehoux, Master's degree

Prata alltid med din läkare eller specialist innan du bestämmer dig för att delta i en studie.

Intresserad av att delta?

Registrera ditt intresse

Dela dina uppgifter och forskarteamet för "Stellate Ganglion Block for Long COVID Symptoms: A Randomize…" kommer att kontakta dig om du kan vara berättigad. Prata alltid med din läkare innan du går med på att delta.

Diskussion

Gemenskapsdiskussion

Drivs av vårt forum på community.patient.info. Var vänlig och respektfull — detta är inte medicinsk rådgivning.